Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):181-9. doi: 10.1097/QAI.0b013e3182174a76.

Abstract

Background: What characterizes individuals whose natural killer (NK) cells are able to respond to HIV-1 peptides is not known.

Methods: The association between NK cell responses and KIR gene profiles and HLA-B and HLA-C alleles was investigated among 76 HIV-1-infected women in South Africa previously categorized as responders (n = 39) or nonresponders (n = 37) to HIV-1 peptide pools in a whole blood intracellular cytokine assay. Viral load was significantly lower and CD4 T-cell counts higher among responders compared with nonresponders (P = 0.023 and P = 0.030, respectively).

Results: Possession of one HLA-C1 allele associated with increased magnitude of NK cell responses to Env (P = 0.031) and significantly decreased viral load (P = 0.027) compared with its absence. There was a trend to increased possession of KIR2DL3+HLA-C1 in responders (71.8% vs 51.4%, P = 0.098) and decreased possession of KIR2DL3/2DL3+C2C2 (2.6% vs 16.2%, P = 0.053). A total of 64.1% of responders versus 32.4% of nonresponders had 13 or more KIR genes (P = 0.0067). Notably, the 13-KIR gene containing the Bx21 genotype (has eight inhibitory and three activating genes KIR2DS2, 2DS4, 2DS5) showed substantially higher representation among the responders (28.2% vs 2.6%, P = 0.001). A significantly higher proportion of responders had both KIR2DS2 and KIR2DS5 compared with either gene alone (72.4% vs 37%; P = 0.015). At least one HLA-C1 allele together with 13 or more KIR genes was associated with NK cell responsiveness (48.7% vs 13.5%; P = 0.001).

Conclusion: NK cell responses to HIV-1 peptides are more likely to occur among individuals with a genotype supporting a more activating NK cell phenotype and who possess at least one HLA-C1 allele.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Viral / blood
  • DNA, Viral / isolation & purification
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation / immunology
  • Genetic Predisposition to Disease
  • Genotype
  • HIV Infections / epidemiology
  • HIV Infections / genetics
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • HLA-B Antigens / genetics
  • HLA-B Antigens / metabolism
  • HLA-C Antigens / genetics*
  • HLA-C Antigens / metabolism
  • Humans
  • Killer Cells, Natural / physiology*
  • Receptors, KIR / genetics*
  • Receptors, KIR / metabolism
  • Receptors, KIR2DL1 / physiology
  • South Africa / epidemiology
  • env Gene Products, Human Immunodeficiency Virus / immunology*

Substances

  • DNA, Viral
  • HLA-B Antigens
  • HLA-C Antigens
  • Receptors, KIR
  • Receptors, KIR2DL1
  • env Gene Products, Human Immunodeficiency Virus